A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants
Condition: Locally Advanced or Metastatic Breast Cancer Intervention: Drug: Eribulin mesylate Sponsor: Eisai Korea Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials